课题基金 / 基金详情

A randomised trial of rapid point-of-care tests for chlamydia and gonorrhoea infections in remote Aboriginal communities

A randomised trial of rapid point-of-care tests for chlamydia and gonorrhoea infections in remote Aboriginal communities
在偏远原住民社区进行衣原体和淋病感染快速现场检测的随机试验
批准号:
nhmrc : 1009902
负责人:
A/Pr David Regan
金额:
$52.59万
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2011
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2011-01-01 至 2014-12-31

项目摘要

项目成果

A/Pr David Regan的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This project will trial a new kind of test for chlamydia and gonorrhoea that can provide immediate results at the time of clinical consultation. The trial will take place in remote Aboriginal communities. These tests have the potential to reduce re-infection rates by ensuring that people with infection have timely treatment. Health services will undertake standard practice in one year, and supplement standard practice by rapid point-of-care testing in the other year in a randomly assigned order.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Modelling the impact of strategies to control gonorrhoea and minimise the threat of antimicrobial resistance in remote Indigenous and other high risk populations
  • 批准号:
    nhmrc : 1145642
  • 项目类别:
    Project Grants
  • 资助金额:
    $31.58万
  • 财政年份:
    2018
  • 负责人:
    A/Pr David Regan
  • 依托单位:
Implementation of an integrated model of chlamydia case management in general practice
  • 批准号:
    nhmrc : GNT1150014
  • 项目类别:
    Partnerships
  • 资助金额:
    $149.72万
  • 财政年份:
    2018
  • 负责人:
    A/Pr David Regan
  • 依托单位:
Modelling the impact of strategies to control gonorrhoea and minimise the threat of antimicrobial resistance in remote Indigenous and other high risk populations
  • 批准号:
    nhmrc : GNT1145642
  • 项目类别:
    Project Grants
  • 资助金额:
    $46.71万
  • 财政年份:
    2018
  • 负责人:
    A/Pr David Regan
  • 依托单位:
Neisseria gonorrhoeae antmicrobial resistance: detection and propagation
  • 批准号:
    nhmrc : 1025517
  • 项目类别:
    Project Grants
  • 资助金额:
    $29.01万
  • 财政年份:
    2012
  • 负责人:
    A/Pr David Regan
  • 依托单位:
国内基金
海外基金
基于移动健康技术干预动脉粥样硬化性心血管疾病高危人群的随机对照现场试验:The ASCVD Risk Intervention Trial
  • 批准号:
    81973152
  • 项目类别:
    面上项目
  • 资助金额:
    54.0万元
  • 批准年份:
    2019
  • 负责人:
    胡东生
  • 依托单位: